Severe Asthma Update: Clinical Management and Key Considerations to Target Optimal Evaluation (ID: i770a)

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. How many patients with severe asthma do you manage?

1 to 25

26 to 50

51 to 100

100+

I am not directly involved in patient care

Question Title

* 3. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

More than 50

26 to 50

11 to 25

1 to 10

I am not directly involved in patient care

Question Title

* 4. Please select the option that best describes your practice setting.

Academic medical center

Community hospital or medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 5. Please rate your level of confidence in your ability for each of the following categories:

5 =Very confident, 4 = Confident, 3 = Neutral, 2 = Little confident, 1 = No confident

	Very confident	Confident	Neutral	Little confidence	No confidence
Diagnose severe asthma and identify biomarkers	Diagnose severe asthma and identify biomarkers Very confident	Diagnose severe asthma and identify biomarkers Confident	Diagnose severe asthma and identify biomarkers Neutral	Diagnose severe asthma and identify biomarkers Little confidence	Diagnose severe asthma and identify biomarkers No confidence
Develop personalized treatment plans for severe asthma	Develop personalized treatment plans for severe asthma Very confident	Develop personalized treatment plans for severe asthma Confident	Develop personalized treatment plans for severe asthma Neutral	Develop personalized treatment plans for severe asthma Little confidence	Develop personalized treatment plans for severe asthma No confidence

Question Title

* 6. Based on what I learned today, I will improve my practice by incorporating the following: (select all that apply)

Improved diagnosis/patient assessment

Useful therapies and appropriate uses

Cutting-edge science in this therapeutic area

Best practices of my colleagues and leaders

I do not plan to make any changes in my practice at this time

Other (please specify)

Question Title

* 7. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 8. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Please rate your level of agreement by checking the appropriate rating.

Question Title

* 9. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma	Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma Strongly agree	Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma Agree	Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma Neutral	Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma Disagree	Apply available guidance to diagnose patients with severe vs difficult-to-treat vs persistent uncontrolled asthma Strongly disagree
Identify biomarkers that define types of severe asthma and utilize results to classify patients	Identify biomarkers that define types of severe asthma and utilize results to classify patients Strongly agree	Identify biomarkers that define types of severe asthma and utilize results to classify patients Agree	Identify biomarkers that define types of severe asthma and utilize results to classify patients Neutral	Identify biomarkers that define types of severe asthma and utilize results to classify patients Disagree	Identify biomarkers that define types of severe asthma and utilize results to classify patients Strongly disagree
Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Strongly agree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Agree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Neutral	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Disagree	Develop personalized treatment plans for patients with severe asthma that are consistent with current evidence-based recommendations Strongly disagree
Identify comorbidities that impact severe asthma treatment and discuss treatment strategies	Identify comorbidities that impact severe asthma treatment and discuss treatment strategies Strongly agree	Identify comorbidities that impact severe asthma treatment and discuss treatment strategies Agree	Identify comorbidities that impact severe asthma treatment and discuss treatment strategies Neutral	Identify comorbidities that impact severe asthma treatment and discuss treatment strategies Disagree	Identify comorbidities that impact severe asthma treatment and discuss treatment strategies Strongly disagree
Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19	Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19 Strongly agree	Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19 Agree	Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19 Neutral	Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19 Disagree	Describe prevention and treatment strategies for patients with severe asthma exposed to coronavirus or diagnosed with COVID-19 Strongly disagree

Question Title

* 10. The faculty presenters effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 11. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 12. Please rate your level of agreement with the following statements:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
The teaching and learning methods were effective	The teaching and learning methods were effective Strongly agree	The teaching and learning methods were effective Agree	The teaching and learning methods were effective Neutral	The teaching and learning methods were effective Disagree	The teaching and learning methods were effective Strongly disagree
The learning assessment used for this activity was appropriate	The learning assessment used for this activity was appropriate Strongly agree	The learning assessment used for this activity was appropriate Agree	The learning assessment used for this activity was appropriate Neutral	The learning assessment used for this activity was appropriate Disagree	The learning assessment used for this activity was appropriate Strongly disagree

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. Credit Request Type:

AMA

ACPE

ANCC

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with severe asthma do you manage?

Question Title

* 3. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

Question Title

* 4. Please select the option that best describes your practice setting.

Question Title

* 5. Please rate your level of confidence in your ability for each of the following categories:5 =Very confident, 4 = Confident, 3 = Neutral, 2 = Little confident, 1 = No confident

Question Title

* 6. Based on what I learned today, I will improve my practice by incorporating the following: (select all that apply)

Question Title

* 7. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 8. What barriers do you see to making changes in your practice?

Question Title

* 9. After participating in today’s activity, I am now able to:

Question Title

* 10. The faculty presenters effectively:

Question Title

* 11. The content presented:

Question Title

* 12. Please rate your level of agreement with the following statements:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. Credit Request Type:

* 5. Please rate your level of confidence in your ability for each of the following categories:

5 =Very confident, 4 = Confident, 3 = Neutral, 2 = Little confident, 1 = No confident